Amneal Pharmaceuticals IncNASDAQ:AMRX
- LAST PRICE8.3500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots7.5300/ 5
- Ask / Lots8.8000/ 5
- Open / Previous Close--- / 8.3500
- Day Range---
- 52 Week Range
- Volume7
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMRX |
|---|---|---|
| 09:32 ET | 6078 | 8.25 |
| 09:33 ET | 400 | 8.25 |
| 09:35 ET | 500 | 8.24 |
| 09:37 ET | 6700 | 8.22 |
| 09:39 ET | 5579 | 8.185 |
| 09:42 ET | 12699 | 8.2 |
| 09:44 ET | 5240 | 8.21 |
| 09:46 ET | 5982 | 8.15 |
| 09:48 ET | 17001 | 8.15 |
| 09:50 ET | 3494 | 8.19 |
| 09:51 ET | 3235 | 8.205 |
| 09:53 ET | 700 | 8.205 |
| 09:55 ET | 300 | 8.205 |
| 09:57 ET | 1059 | 8.195 |
| 10:00 ET | 2530 | 8.2 |
| 10:02 ET | 2594 | 8.21 |
| 10:04 ET | 9735 | 8.205 |
| 10:06 ET | 1832 | 8.17 |
| 10:08 ET | 1100 | 8.165 |
| 10:09 ET | 1811 | 8.175 |
| 10:11 ET | 1000 | 8.175 |
| 10:13 ET | 1027 | 8.155 |
| 10:15 ET | 100 | 8.155 |
| 10:18 ET | 10221 | 8.195 |
| 10:20 ET | 1300 | 8.195 |
| 10:22 ET | 5900 | 8.195 |
| 10:24 ET | 2000 | 8.195 |
| 10:26 ET | 6820 | 8.195 |
| 10:27 ET | 800 | 8.19 |
| 10:29 ET | 1000 | 8.195 |
| 10:31 ET | 904 | 8.185 |
| 10:33 ET | 3354 | 8.165 |
| 10:36 ET | 786 | 8.165 |
| 10:38 ET | 5494 | 8.19 |
| 10:40 ET | 802 | 8.17 |
| 10:42 ET | 1100 | 8.1703 |
| 10:44 ET | 6654 | 8.24 |
| 10:45 ET | 700 | 8.225 |
| 10:47 ET | 300 | 8.22 |
| 10:49 ET | 4538 | 8.22 |
| 10:51 ET | 1155 | 8.24 |
| 10:54 ET | 975 | 8.235 |
| 10:56 ET | 100 | 8.245 |
| 10:58 ET | 2350 | 8.245 |
| 11:02 ET | 5731 | 8.18 |
| 11:03 ET | 4016 | 8.2 |
| 11:07 ET | 856 | 8.21 |
| 11:09 ET | 13809 | 8.21 |
| 11:12 ET | 1386 | 8.23 |
| 11:14 ET | 16492 | 8.17 |
| 11:16 ET | 1924 | 8.17 |
| 11:18 ET | 3100 | 8.19 |
| 11:20 ET | 3278 | 8.19 |
| 11:21 ET | 2767 | 8.17 |
| 11:23 ET | 3262 | 8.165 |
| 11:25 ET | 4752 | 8.17 |
| 11:27 ET | 3025 | 8.16 |
| 11:32 ET | 3983 | 8.16 |
| 11:34 ET | 3650 | 8.18 |
| 11:36 ET | 4330 | 8.195 |
| 11:38 ET | 2842 | 8.22 |
| 11:39 ET | 10085 | 8.24 |
| 11:41 ET | 12679 | 8.23 |
| 11:43 ET | 1980 | 8.24 |
| 11:45 ET | 3875 | 8.24 |
| 11:48 ET | 2183 | 8.24 |
| 11:50 ET | 2700 | 8.24 |
| 11:52 ET | 3784 | 8.2427 |
| 11:54 ET | 1051 | 8.25 |
| 11:56 ET | 2174 | 8.25 |
| 11:57 ET | 100 | 8.255 |
| 11:59 ET | 1912 | 8.2701 |
| 12:01 ET | 2976 | 8.265 |
| 12:03 ET | 300 | 8.265 |
| 12:06 ET | 3177 | 8.295 |
| 12:08 ET | 566 | 8.29 |
| 12:10 ET | 4616 | 8.29 |
| 12:12 ET | 1000 | 8.29 |
| 12:14 ET | 5840 | 8.3 |
| 12:15 ET | 2022 | 8.32 |
| 12:17 ET | 1576 | 8.305 |
| 12:19 ET | 952 | 8.31 |
| 12:21 ET | 1200 | 8.32 |
| 12:24 ET | 1775 | 8.315 |
| 12:26 ET | 3275 | 8.295 |
| 12:28 ET | 1150 | 8.2901 |
| 12:30 ET | 239 | 8.3 |
| 12:32 ET | 345 | 8.295 |
| 12:33 ET | 11900 | 8.31 |
| 12:37 ET | 600 | 8.31 |
| 12:42 ET | 3814 | 8.325 |
| 12:44 ET | 1400 | 8.33 |
| 12:46 ET | 1856 | 8.32 |
| 12:48 ET | 1058 | 8.315 |
| 12:50 ET | 2197 | 8.33 |
| 12:51 ET | 4289 | 8.345 |
| 12:53 ET | 500 | 8.35 |
| 12:55 ET | 1600 | 8.35 |
| 12:57 ET | 1244 | 8.335 |
| 01:00 ET | 200 | 8.335 |
| 01:02 ET | 261 | 8.335 |
| 01:04 ET | 258 | 8.33 |
| 01:06 ET | 700 | 8.34 |
| 01:08 ET | 739 | 8.335 |
| 01:09 ET | 113 | 8.335 |
| 01:11 ET | 1787 | 8.35 |
| 01:13 ET | 100 | 8.345 |
| 01:18 ET | 2551 | 8.3481 |
| 01:20 ET | 2362 | 8.35 |
| 01:26 ET | 218 | 8.345 |
| 01:27 ET | 3228 | 8.355 |
| 01:29 ET | 1443 | 8.345 |
| 01:31 ET | 11664 | 8.33 |
| 01:33 ET | 218 | 8.33 |
| 01:36 ET | 300 | 8.32 |
| 01:38 ET | 300 | 8.3165 |
| 01:40 ET | 1036 | 8.32 |
| 01:42 ET | 1400 | 8.32 |
| 01:44 ET | 666 | 8.33 |
| 01:45 ET | 100 | 8.325 |
| 01:47 ET | 100 | 8.32 |
| 01:49 ET | 2075 | 8.315 |
| 01:51 ET | 800 | 8.3199 |
| 01:54 ET | 727 | 8.32 |
| 01:56 ET | 100 | 8.32 |
| 01:58 ET | 881 | 8.3208 |
| 02:00 ET | 604 | 8.33 |
| 02:03 ET | 274 | 8.3101 |
| 02:07 ET | 1449 | 8.315 |
| 02:09 ET | 1218 | 8.31 |
| 02:12 ET | 1254 | 8.31 |
| 02:14 ET | 400 | 8.3168 |
| 02:16 ET | 7744 | 8.295 |
| 02:18 ET | 418 | 8.295 |
| 02:21 ET | 300 | 8.295 |
| 02:23 ET | 21865 | 8.325 |
| 02:25 ET | 4888 | 8.295 |
| 02:27 ET | 300 | 8.295 |
| 02:30 ET | 1232 | 8.29 |
| 02:34 ET | 2647 | 8.295 |
| 02:36 ET | 9037 | 8.305 |
| 02:38 ET | 2000 | 8.295 |
| 02:39 ET | 2125 | 8.31 |
| 02:43 ET | 250 | 8.305 |
| 02:45 ET | 248 | 8.305 |
| 02:48 ET | 1600 | 8.3 |
| 02:50 ET | 1188 | 8.305 |
| 02:54 ET | 799 | 8.3 |
| 02:56 ET | 1000 | 8.31 |
| 02:57 ET | 241 | 8.305 |
| 02:59 ET | 596 | 8.305 |
| 03:01 ET | 342 | 8.305 |
| 03:03 ET | 1694 | 8.305 |
| 03:06 ET | 100 | 8.305 |
| 03:08 ET | 12490 | 8.325 |
| 03:10 ET | 572 | 8.325 |
| 03:12 ET | 431 | 8.325 |
| 03:14 ET | 3627 | 8.31 |
| 03:15 ET | 1022 | 8.305 |
| 03:17 ET | 1902 | 8.31 |
| 03:19 ET | 100 | 8.32 |
| 03:21 ET | 625 | 8.3188 |
| 03:24 ET | 216 | 8.32 |
| 03:26 ET | 1495 | 8.315 |
| 03:28 ET | 300 | 8.315 |
| 03:30 ET | 2986 | 8.33 |
| 03:32 ET | 1000 | 8.325 |
| 03:35 ET | 11756 | 8.34 |
| 03:37 ET | 2054 | 8.335 |
| 03:39 ET | 8033 | 8.35 |
| 03:42 ET | 3551 | 8.35 |
| 03:44 ET | 2912 | 8.345 |
| 03:46 ET | 14256 | 8.35 |
| 03:48 ET | 1792 | 8.345 |
| 03:50 ET | 10375 | 8.35 |
| 03:51 ET | 23107 | 8.35 |
| 03:53 ET | 32565 | 8.355 |
| 03:55 ET | 42474 | 8.35 |
| 03:57 ET | 41023 | 8.355 |
| 04:00 ET | 165853 | 8.35 |
Nov 21, 2024
DJ Amneal Resubmits New Drug Application for Migraine Treatment, Diabetes Drug Is Approved, from 5:05PM ET on Thursday Nov 21, 2024 by Dow Jones
5:05PM ET on Thursday Nov 21, 2024 by Dow JonesAmneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist, from 4:05PM ET on Thursday Nov 21, 2024 by Dow Jones
4:05PM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 11, 2024
DJ Amneal Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 8:46AM ET on Monday Nov 11, 2024 by Dow Jones
8:46AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 8, 2024
DJ Amneal Pharmaceuticals Swings to 3Q Loss While Sales Climb, from 6:18AM ET on Friday Nov 08, 2024 by Dow Jones
6:18AM ET on Friday Nov 08, 2024 by Dow JonesAmneal Reports Third Quarter 2024 Financial Results, from 6:00AM ET on Friday Nov 08, 2024 by Dow Jones
6:00AM ET on Friday Nov 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amneal Pharmaceuticals Inc | 2.6B | -12.2x | --- |
Endo Inc | 1.8B | 0.4x | --- |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 4.2B | 20.5x | --- |
PTC Therapeutics Inc | 3.5B | -7.6x | --- |
HUTCHMED (China) Ltd | 3.1B | -73.8x | --- |
Company Information
Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Company’s Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company's Specialty segment’s portfolio includes central nervous system disorders (Parkinson’s disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Company’s AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.
Contact Information
- Headquarters
- 400 Crossing Boulevard, 3rd FloorBRIDGEWATER, NJ, United States 08807
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Paul Meister
- President, Co-Chief Executive Officer, Co-Founder, Director
- Chirag Patel
- Co-Chief Executive Officer, Co-Founder, Director
- Chintu Patel
- Chief Financial Officer, Executive Vice President
- Anastasios Konidaris
- Chief Human Resource Officer, Executive Vice President
- Nikita Shah
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $2.7B |
Shares Outstanding | 309.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.13 |
EPS | $-0.68 |
Book Value | $0.04 |
P/E Ratio | -12.2x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | 31.7x |
Operating Margin | 7.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
